FlexShares ESG & Climate Investment Grade Corporate Core Index Fund (ARCA: FEIG)

Latest news for FlexShares ESG & Climate Investment Grade Corporate Core Index Fund (ARCA:FEIG)

Other

Financial Services

The Underlying Index seeks to reflect the performance of a selection of U.S.-dollar-denominated corporate bonds issued by companies that exhibit certain environmental, social and governance (ESG) characteristics, while also seeking to provide broad-market, core exposure to U.S.-dollar-denominated investment grade corporate bonds of U.S. and non‘U.S. issuers. The Underlying Index is designed to minimize tracking differences relative to the Northern Trust US Corporate Bond Index (the Parent Index) while also seeking (a) an aggregate higher scoring of certain ESG characteristics, as measured by the Northern Trust ESG Vector Score (ESG Vector Score) described below, and (b) reduction of aggregate climate-related risk, as measured by certain carbon-related risk metrics, each relative to its Parent Index. The Underlying Index also excludes certain companies by using controversial business involvement and norms-based screens.

FlexShares ESG & Climate Investment Grade Corporate Core Index Fund

FIDELITY SUS EUR CORP BOND ETF INC

DoorDash, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) stock surged Wednesday after KeyBanc analyst Justin Patterson upgraded the stock from Sector Weight to Overweight with a&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/DASH/analyst-ratings" rel="noreferrer noopener">$177&nbsp;price target</a>.
Patterson noted DoorDash as a clear share gainer in a secular growth category with emerging revenue streams from advertising and new verticals like grocery.
When Patterson initiated DoorDash before <a target="_blank" href="https://www.benzinga.com/news/earnings/24/08/40116158/doordash-q2-earnings-revenue-beat-eps-miss-total-orders-up-19-results-reflect-years-of-investment-a'" rel="noreferrer noopener">second-quarter earnings</a>, he was constructive on DoorDash&#8217;s fundamentals and long-term opportunity but cautious on near-term consumer spending data points, particularly around restaurants.
The analyst told DoorDash&#8217;s second-quarter results eased many concerns about any significant impact from weaker consumer spending. Additionally, a broader set of reports showed resilience, and he left the second quarter viewing consumer softness as more localized than widespread.
His latest survey results reinforced that DoorDash is still distancing peers in food delivery and showing early signs of success with grocery.
In turn, the analyst noted that consensus is understating both Gross Order Volume (GOV) and EBITDA growth in 2025E (he is 2% and 3% above consensus) and 2026E (he is 3% and 6% above consensus). Rolling forward a 20 times Enterprise Value to EBITDA valuation to 2026E, Patterson reached a price target of $177.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/09/41025133/doordash-stock-is-moving-higher-wednesday-whats-going-on" rel="noreferrer noopener">DoorDash Stock Is Moving Higher Wednesday: What&#8217;s Going On?</a>
After reviewing Patterson&#8217;s third-quarter Mobility and Delivery Survey and model assumptions, he became more confident that DoorDash is gaining ground in its core and emerging verticals. This should sustain over 15% GOV growth and drive EBITDA of $3.5 billion by 2026E (~6% above consensus).
Patterson&#8217;s latest survey showed ongoing gains in food delivery usage, with 39% using DoorDash the most, 23 points above Uber Technologies, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), and in grocery, 8% using DoorDash the most, up by 300 bps since December 2023.
The analyst noted a strong core and ramp in new verticals should support his revised estimates for ~17% and 15% GOV growth in 2025E and 2026E (versus consensus of 15% and 13%) and EBITDA of $2.6 billion and $3.5 billion (3% and 6% above consensus).
Price Action: DASH stock is up 1.27% at $143.48 at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40150236/doordash-and-exact-sciences-are-among-top-10-large-cap-gainers-last-week-july-28-aug-3-are-the-other" target="_blank" rel="noreferrer noopener">DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?</a></li>
</ul>
Photo courtesy: Shutterstock

Analyst Color

News

Upgrades

Price Target

Analyst Ratings

Movers

Tech

Trading Ideas

DASH

UBER

DoorDash Positioned As Clear Market Share Gainer With Growth In Grocery And Ads, Analyst Says, Upgrades Stock

Morgan Stanley analyst Stephen Byrd maintains Ameren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEE#NYSE">AEE</a>) with a Equal-Weight and raises the price target from $81 to $85.

Morgan Stanley Maintains Equal-Weight on Ameren, Raises Price Target to $85

USW Says We Disagree With Result Of Board Of Arbitration's Decision Over Grievances Against U.S. Steel; "Nippon's Commitment To Our Facilities And Jobs Remains Uncertain As Ever"

Barclays analyst Trevor Young maintains GoDaddy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDDY#NYSE">GDDY</a>) with a Overweight and raises the price target from $165 to $185.

GDDY

Barclays Maintains Overweight on GoDaddy, Raises Price Target to $185

Opentrons, a Long Island City-based biotech company, is at the forefront of the robot revolution. Known for its cutting-edge AI-powered robots, Opentrons is revolutionizing scientific research, particularly in health care. Backed by prominent investors like Bill Gates, the company is dramatically reducing costs in the biotech space by automating complex lab procedures, making science more accessible and efficient.
Don't Miss:
<ul>
<li>Don&#8217;t miss the real AI boom &#8211;<a href="https://www.benzinga.com/money/fundrise-innovation-fund"> here&#8217;s how to use just $10 to invest in high growth private tech companies.</a></li>
<li>Unlock a $400 billion opportunity by investing in the future of EV infrastructure on<a href="https://www.benzinga.com/money/dunamis-1"> this startup already valued at $50 million with just $500</a>.</li>
</ul>
Bill Gates has long been an advocate for global health initiatives. He donates heavily to fund <a href="https://www.benzinga.com/personal-finance/24/08/40667041/bill-gates-100m-alzheimers-research-support-his-visit-to-iu-school-of-medicine-and-how-he-recomm">Alzheimer's research</a> and the Bill and Melinda Gates Foundation also heads the <a href="https://www.benzinga.com/personal-finance/24/09/40794858/bill-gates-efforts-to-eradicate-malaria-and-the-economic-impact-of-ridding-the-globe-of-this-dis">fight against malaria</a> to eradicate the disease. So, it's no surprise that Gates is backing this innovative tech company.&nbsp;
Gates' involvement with Opentrons takes them one step closer to fulfilling their mission to make advanced technology accessible to scientists worldwide. According to the New York Post, Gates helped connect the company to rural African villages that needed the tech devices.&nbsp;
Trending: Teens may never need wisdom teeth removed thanks to this MedTech Company –<a href="https://www.benzinga.com/money/triagenics"> Be an early investor for just $300 for 100 shares!</a>
Jonathan Brennan-Badal, Opentrons' CEO, shared Gates' vision during an interview with The Post, saying, "His principle interest really is around how we can be building a platform and ecosystem … enabling third-party developers like other startups, scientists to build new applications for our robot, build new devices, hardware devices that can integrate with our platform."
Opentrons has integrated AI tools like <a href="https://www.benzinga.com/news/24/09/40890661/chatgpt-parent-openai-establishes-oversight-committee-for-safety-amid-recent-fears-of-biological-wea">ChatGPT</a> and large language models (LLM) into their robots to simplify the programming process. This allows scientists to use simple prompts, like "run a COVID test," without requiring extensive coding knowledge to get the robot to work. Once the prompt is said, the robot takes care of the rest.&nbsp;
These robots are saving scientists time and money worldwide. They are already deployed in 14 of the 15 leading global pharmaceutical companies, performing tasks such as sequencing DNA and intricate lab tests. They are transforming how scientists conduct their research.&nbsp;
Trending: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.
On the topic of saving money, Opentrons' robots played a significant role during the COVID-19 pandemic. The company set up a Pandemic Response Lab (PRL) in 2020 and used 40 of its robots to conduct over 12 million COVID tests in New York City. This automation saved the city and taxpayers roughly 80% of the cost, approximating around $600 billion in savings. These robots were also the first to identify new variants of COVID-19, including Omicron.&nbsp;
Beyond the cost savings to taxpayers and scientists, the price point for Opentrons robots is also appealing. The robots start at $10,000, significantly more affordable than leading competitors, who charge around $100,000.&nbsp;
Trending: Will the surge continue or decline on real estate prices?<a href="https://www.benzinga.com/money/realbricks"> People are finding out about risk-free real estate investing that lets you cash out whenever you want.</a>
A more affordable robot like this allows smaller labs and research facilities to access this advanced technology worldwide. Opentrons' mission goes beyond just making a more affordable solution though. It's important that their robots are portable too. Their robots have been used in remote locations – and can even run on car batteries – to test for disease outbreaks.&nbsp;
Opentrons' innovation doesn't stop at testing. The company is working on reducing the astronomical costs of gene therapy, which currently exceeds $1 million per treatment. By leveraging <a href="https://www.benzinga.com/content/40971485/robotics-industry-growth-brings-new-jobs-and-housing-market-demand-to-colorado">robotics</a> and automation, Opentrons aims to reduce these costs to $30,000 or less, making lifesaving treatments accessible to a broader population.
Read Next:
<ul>
<li>Founder of Personal Capital and ex-CEO of PayPal<a href="https://www.benzinga.com/money/evergreen-money"> re-engineers traditional banking with this new high-yield account — start saving better today.</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Startups

Bill Gates Backs NYC's Robot Revolution: Opentrons AI Changing Science And Medicine With Robot Pricing Starting At $10,000

Financial giants have made a conspicuous bullish move on AST SpaceMobile. Our analysis of options history for AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) revealed 24 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 11 were puts, with a value of $1,468,076, and 13 were calls, valued at $534,208.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $35.0 for AST SpaceMobile over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in AST SpaceMobile's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to AST SpaceMobile's substantial trades, within a strike price spectrum from $10.0 to $35.0 over the preceding 30 days.
<h3>AST SpaceMobile Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727279132_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ASTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.47</td>
<td>$22.50</td>
<td>$547.3K</td>
<td style="text-align: right;">128</td>
<td>2.4K</td>
</tr>
<tr>
<td>ASTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.48</td>
<td>$22.50</td>
<td>$411.6K</td>
<td style="text-align: right;">128</td>
<td>1.4K</td>
</tr>
<tr>
<td>ASTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$18.5</td>
<td>$15.9</td>
<td>$18.29</td>
<td>$30.00</td>
<td>$109.0K</td>
<td style="text-align: right;">88</td>
<td>60</td>
</tr>
<tr>
<td>ASTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$5.6</td>
<td>$5.5</td>
<td>$5.53</td>
<td>$22.50</td>
<td>$82.9K</td>
<td style="text-align: right;">128</td>
<td>233</td>
</tr>
<tr>
<td>ASTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.5</td>
<td>$22.50</td>
<td>$82.5K</td>
<td style="text-align: right;">128</td>
<td>256</td>
</tr>
</tbody>
</table>

<h3>About AST SpaceMobile</h3>
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers and finally bringing broadband to the billions who remain unconnected. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
After a thorough review of the options trading surrounding AST SpaceMobile, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of AST SpaceMobile</h3>
<ul>
<li>Currently trading with a volume of 4,693,679, the ASTS's price is down by -3.33%, now at $24.99. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 48 days.</li>
</ul>
<h3>What The Experts Say On AST SpaceMobile</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $49.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from B. Riley Securities continues to hold a Buy rating for AST SpaceMobile, targeting a price of $36. 
&#x2A; An analyst from Deutsche Bank persists with their Buy rating on AST SpaceMobile, maintaining a target price of $63. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AST SpaceMobile, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

ASTS

Decoding AST SpaceMobile's Options Activity: What's the Big Picture?

Financial giants have made a conspicuous bearish move on Regeneron Pharmaceuticals. Our analysis of options history for Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) revealed 12 unusual trades.
Delving into the details, we found 16% of traders were bullish, while 58% showed bearish tendencies. Out of all the trades we spotted, 10 were puts, with a value of $445,523, and 2 were calls, valued at $67,950.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $750.0 and $1170.0 for Regeneron Pharmaceuticals, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Regeneron Pharmaceuticals's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Regeneron Pharmaceuticals's whale activity within a strike price range from $750.0 to $1170.0 in the last 30 days. 
<h3>Regeneron Pharmaceuticals Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727279127_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$30.7</td>
<td>$26.7</td>
<td>$30.7</td>
<td>$1040.00</td>
<td>$122.8K</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">41</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$46.5</td>
<td>$41.0</td>
<td>$44.6</td>
<td>$1000.00</td>
<td>$44.6K</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">15</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$144.0</td>
<td>$137.5</td>
<td>$139.66</td>
<td>$1170.00</td>
<td>$41.8K</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">3</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/27/24</td>
<td>$97.0</td>
<td>$96.9</td>
<td>$97.0</td>
<td>$1120.00</td>
<td>$38.8K</td>
<td style="text-align: right;">89</td>
<td style="text-align: right;">25</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$100.7</td>
<td>$94.6</td>
<td>$96.6</td>
<td>$1120.00</td>
<td>$38.6K</td>
<td style="text-align: right;">89</td>
<td style="text-align: right;">29</td>
</tr>
</tbody>
</table>

<h3>About Regeneron Pharmaceuticals</h3>
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia).
Following our analysis of the options activities associated with Regeneron Pharmaceuticals, we pivot to a closer look at the company's own performance.
<h3>Current Position of Regeneron Pharmaceuticals</h3>
<ul>
<li>Currently trading with a volume of 389,940, the REGN's price is down by -1.07%, now at $1034.78. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 36 days.</li>
</ul>
<h3>Expert Opinions on Regeneron Pharmaceuticals</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $1184.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from RBC Capital downgraded its action to Outperform with a price target of $1282. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Neutral with a new price target of $1015. 
&#x2A; An analyst from Leerink Partners downgraded its action to Market Perform with a price target of $1077. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $1250. 
&#x2A; In a cautious move, an analyst from BMO Capital downgraded its rating to Outperform, setting a price target of $1300. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Regeneron Pharmaceuticals with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

REGN

A Closer Look at Regeneron Pharmaceuticals's Options Market Dynamics

Barclays analyst Michael Leithead maintains Kronos Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRO#NYSE">KRO</a>) with a Underweight and raises the price target from $9 to $10.

Barclays Maintains Underweight on Kronos Worldwide, Raises Price Target to $10

Macro Notification

General

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

Biden Says An All-Out War Is Possible In Middle East, But There Also Is Possibility Of A Settlement; There Needs To Be A Two-State Solution For Israel-Palestine

Financial giants have made a conspicuous bullish move on Kohl's. Our analysis of options history for Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) revealed 12 unusual trades.
Delving into the details, we found 66% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $536,471, and 5 were calls, valued at $300,562.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $12.5 to $22.0 for Kohl's during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Kohl's stands at 1086.33, with a total volume reaching 9,469.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Kohl's, situated within the strike price corridor from $12.5 to $22.0, throughout the last 30 days.
<h3>Kohl's 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727279122_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>KSS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$2.31</td>
<td>$2.27</td>
<td>$2.31</td>
<td>$22.00</td>
<td>$162.6K</td>
<td>1.2K</td>
<td>2.1K</td>
</tr>
<tr>
<td>KSS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$2.38</td>
<td>$2.26</td>
<td>$2.26</td>
<td>$22.00</td>
<td>$129.9K</td>
<td>1.2K</td>
<td>1.2K</td>
</tr>
<tr>
<td>KSS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$8.75</td>
<td>$8.5</td>
<td>$8.75</td>
<td>$12.50</td>
<td>$120.7K</td>
<td>13</td>
<td>138</td>
</tr>
<tr>
<td>KSS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$2.3</td>
<td>$2.29</td>
<td>$2.29</td>
<td>$22.00</td>
<td>$93.0K</td>
<td>1.2K</td>
<td>0</td>
</tr>
<tr>
<td>KSS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$8.75</td>
<td>$8.5</td>
<td>$8.75</td>
<td>$12.50</td>
<td>$81.3K</td>
<td>13</td>
<td>344</td>
</tr>
</tbody>
</table>

<h3>About Kohl's</h3>
Kohl's operates about 1,176 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 26% of its 2023 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Having examined the options trading patterns of Kohl's, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Kohl's</h3>
<ul>
<li>With a volume of 2,143,963, the price of KSS is up 0.76% at $19.91. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 55 days.</li>
</ul>
<h3>Professional Analyst Ratings for Kohl's</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $21.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Evercore ISI Group has decided to maintain their In-Line rating on Kohl's, which currently sits at a price target of $20. 
&#x2A; Consistent in their evaluation, an analyst from Baird keeps a Outperform rating on Kohl's with a target price of $25. 
&#x2A; In a cautious move, an analyst from TD Cowen downgraded its rating to Hold, setting a price target of $21. 
&#x2A; In a cautious move, an analyst from JP Morgan downgraded its rating to Underweight, setting a price target of $19. 
&#x2A; Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Market Perform rating on Kohl's with a target price of $23. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Kohl's, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Kohl's Unusual Options Activity For September 25

Barclays analyst Michael Leithead maintains Tronox Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) with a Overweight and lowers the price target from $19 to $18.

TROX

Barclays Maintains Overweight on Tronox Holdings, Lowers Price Target to $18

TTWO

Ubisoft Updates Financial Targets For FY2024-25; Assassin's Creed Shadows Set For February 14, 2025 Release; Q2 FY2024-25 Net Bookings Expected Around €350-€370M

BlackSky Technology Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NYSE">BKSY</a>) shares are trading lower by 16.9% to $4.19 during Wednesday&#8217;s session after the company announced the pricing of a $40 million public offering of 10 million shares at <a href="https://www.benzinga.com/pressreleases/24/09/b41023809/blacksky-announces-pricing-of-upsized-40-million-public-offering-of-common-stock">$4.00 per share</a>.
The offering, solely from BlackSky, is set to close around September 26, pending standard conditions. The company has also granted underwriters a 30-day option to purchase an additional 1.5 million shares. 
Oppenheimer &amp; Co. and Lake Street Capital Markets are serving as joint book-running managers for the offering.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41024067/mortgage-demand-soars-as-fed-interest-rate-cut-fuels-housing-market-revival-next-sp">Mortgage Demand Soars As Fed Interest Rate Cut Fuels Housing Market Revival: &#8216;Next Spring Could See A Real Rebound&#8217;</a>
<h2 class="wp-block-heading">Should I Sell My BKSY Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Shares of BlackSky Technology have lost 58.13% year to date. This compares to the average annual return of -62.04%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. 
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
BKSY has a 52-week high of $14.16 and a 52-week low of $3.86.

BlackSky Technology Inc. Class A Common Stock

BKSY

Why BlackSky Technology (BKSY) Stock Is Down 20% Today

Tropical Storm Helene is forecasted to turn <a href="https://www.benzinga.com/markets/equities/24/08/40259269/storm-debby-headed-for-nyc-highly-populated-areas-as-catastrophic-flooding-persists">into a hurricane</a> as it makes landfall over Florida on Thursday.
The storm was located about 60 miles northeast of Cozumel, Mexico, Wednesday morning, moving northwest at 9 mph with maximum sustained winds of 70 mph, according to the National Weather Service (NWS).
The storm is expected to strengthen into a hurricane as it passes over the Gulf of Mexico&#8217;s eastern coast later Wednesday and into Thursday and reaches the Big Bend of Florida late Thursday.
The NWS has already issued a tropical storm warning for all of the Florida Keys, the state&#8217;s west coast from Flamingo to Anclote River, including Tampa Bay, and the Florida east coast from Flamingo northward to Altamaha Sound, Georgia. 
Read Also: <a href="https://www.benzinga.com/markets/equities/24/09/40982087/shell-braces-for-tropical-storm-35-prepares-major-gulf-of-mexico-oil-fields-for-shut-down">Shell Braces For Tropical Storm 35: Prepares Major Gulf Of Mexico Oil Fields For Shut Down</a>
Helene is forecasted to produce 5 to 10 inches of rain, with isolated totals of 15 inches over the southeastern U.S. This will likely result in considerable urban and flash flooding and significant river flooding. It may also cause landslides in steep terrain areas in the southern Appalachians.
Helene is also expected to bring 4 to 8 inches of rain to Cuba, the Cayman Islands and the northern Yucatan Peninsula before reaching the U.S.
Price Action: The approaching storm has impacted stocks of generator producers, retailers, and utility companies with a presence or a subsidiary in Florida.
Generators
<ul>
<li>Generac Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNRC#NYSE">GNRC</a>) slipped 0.45% to $150.16</li>
<li>Cummins Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) declined 0.55% to $321.78</li>
<li>Honda Motor Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) rose 0.27% to $32.83</li>
</ul>
Retailers
<ul>
<li>Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) gained 0.56% to $81.12</li>
<li>Target Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) slipped 0.4% to $155.56</li>
<li>The Home Depot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) fell 0.67% to $397.99</li>
</ul>
Utilities 
<ul>
<li>Emera Incorporated (TSX:<a class="ticker" href="https://www.benzinga.com/stock/EMA#TSX">EMA</a>) gained 0.55% to $52.83</li>
<li>Duke Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>) slipped 0.12% to $115.85</li>
</ul>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39581491/whats-going-on-with-cruise-stocks-as-category-4-hurricane-beryl-churns-in-the-caribbean">What&#8217;s Going On With Cruise Stocks As Category 4 Hurricane Beryl Churns In the Caribbean?</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Retail Sales

GNRC

TSX:EMA

Tropical Storm Helene Set To Become Hurricane: Generac, Duke Energy Stocks React As Florida Braces

WIIM

Trump Media & Technology Group shares are trading higher amid possible volatility ahead of the 2024 US presidential election.

Barclays analyst Michael Leithead maintains Chemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>) with a Equal-Weight and lowers the price target from $22 to $21.

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $21

Rumors

PRAA

Watching PRA Group; Shares See Volume As Traders Circulate Stock Picked By Popular Newsletter Service

As Tropical Storm Helene intensifies and approaches Florida's Gulf Coast, Trulieve Cannabis Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>), one of the largest multi-state operators (MSOs) in the U.S. weed industry, is bracing for potential disruptions. Investors have voiced concerns about the storm's potential impact on operations, especially given Trulieve's extensive footprint in Florida. However, Trulieve&#8217;s CEO Kim Rivers says the company is fully prepared for what's coming ashore.
In a Twitter exchange responding to user @WolfOfWeedST, Rivers laid out the company's readiness plans, noting that it&#8217;s facilities are built to withstand the storm. &#8220;We are locked and loaded. Not our first storm rodeo. Buildings are all wind rated and have all been thru storms in the past,&#8221; Rivers wrote, addressing concerns about infrastructure vulnerabilities as Helene strengthens into a potentially catastrophic event.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We are locked and loaded. Not our first storm rodeo. Buildings are all wind rated and have all been thru storms in the past. The biggest threat is loss of power but lines come from the southeast so that's looking ok. Regardless, generators are on site, storm prep done and teams…
&mdash; Kim Rivers (@rivers_kim) <a href="https://twitter.com/rivers_kim/status/1838931491704721750?ref_src=twsrc%5Etfw">September 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">A Storm On The Horizon</h3>
Helene, which is expected to make landfall as a major hurricane, poses a significant threat to Florida's west coast. The National Hurricane Center (NHC) has already issued warnings for storm surges that could reach up to 15 feet, along with wind speeds forecasted to exceed 100 mph as the storm intensifies. Counties along the Florida coast have begun issuing evacuation orders and power outages are expected.
Trulieve's headquarters, operations and dispensaries are heavily concentrated in Florida, making the company particularly vulnerable to disruptions. But Rivers assured stakeholders that the company's hurricane preparedness plan has been activated. While acknowledging that the biggest challenge could be power outages, she remained optimistic. "The biggest threat is loss of power but lines come from the southeast so that's looking ok. Regardless, generators are on site, storm prep done and teams ready to go."
<h3 class="wp-block-heading">Impact On Cannabis Supply Chain</h3>
Given that Trulieve also supplies wholesale cannabis products to other operators, any disruption to its facilities could ripple throughout the supply chain.
Cannabis investors are watching closely, with some expressing concern over potential setbacks to the cannabis industry's recovery after a challenging several years. @WolfOfWeedST pointed out, "The only thing that can screw up A3 [Amendment 3, the initiative to legalize adult-use cannabis in the state] and this run is hurricane Helene for the MSO's in Florida," highlighting the dependency of several players on Trulieve's production and wholesale operations.
As the cannabis industry watches closely, Helene's path will be a key focus in the coming days. While the physical infrastructure is in place, the true test will come in the aftermath of the storm, when the focus will shift to how quickly operations can resume and whether supply chains remain intact.
Here&#8217;s hoping everyone remains safe and sound.

Cannabis

TCNNF

Will Hurricane Helene Disrupt Florida's Cannabis Industry? Trulieve CEO Says Co. Is 'Locked And Loaded, Not Our First Storm Rodeo'

JP Morgan analyst Mark Strouse maintains Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEPC#NYSE">BEPC</a>) with a Neutral and raises the price target from $33 to $34.

BEPC

JP Morgan Maintains Neutral on Brookfield Renewable, Raises Price Target to $34

It gave pedestrians room but ran red lights and crossed into oncoming traffic. &nbsp;
Tesla's controversial "Full Self Driving" is now capable of some quite advanced driving. But that can breed undeserved complacency, according to independent testing. The partially automated driving system exhibited dangerous behavior that required human intervention more than 75 times over the course of more than 1,000 miles (1,600 km) of driving in Southern California, averaging one intervention every 13 miles (21 km).
<a href="https://arstechnica.com/cars/2024/09/tesla-full-self-driving-requires-human-intervention-every-13-miles/" title="https://arstechnica.com/cars/2024/09/tesla-full-self-driving-requires-human-intervention-every-13-miles/">https://arstechnica.com/cars/2024/09/tesla-full-self-driving-requires-human-intervention-every-13-miles/</a>

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

FlexShares ESG & Climate Investment Grade Corporate Core Index Fund

News

Latest news for FlexShares ESG & Climate Investment Grade Corporate Core Index Fund (ARCA:FEIG)